Panchsheel Organics
- Market cap
- ₹ 127 Cr.
- P/E
- 13.3x
- P/B
- 0.96x
- 52-week range
- 86.1 – 154.4
- ROE
- 8%
- ROCE
- 10%
- Dividend yield
- 3.1%
- Debt / equity
- 0.04
- Sector
- Pharmaceuticals & Biotechnology
- Industry
- Pharmaceuticals
- Listed on
- BSE
About
Panchsheel Organics Limited is an India-based manufacturer and exporter of active pharma ingredients (APIs), intermediates and finished formulations (both human and veterinary). The Company operates through the manufacturing and trading of the bulk drug and intermediate segment. Its specialties include steroids and hormones, veterinary products, over-the-counter products, oncology products, nutraceutical products, micro pellets and direct compression granules, fitness and healthcare, and product development and nutraceuticals. The Company offers a range of products under categories, such as cardiovascular, neuropsychiatry, antifungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, among others. It manufactures bio fertilizers, organic fertilizers, different products of insecticides, herbicides, pesticides, fungicides, viricides, water-soluble fertilizers, plant growth regulators, and fertilizer nutrients. The Company also offers bio specialty chemicals.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pharmaceuticals: 221 companies →Panchsheel Organics against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)13.3 against a typical 34.3: cheaper than most peers (1st = cheapest).33rd of 220
- Sales growth+4.7% against a typical +15.6% from a year earlier.136th of 197
- Profit growth−18.9% against a typical +18.9% from a year earlier.113th of 160
- Share price, 3 months−13.5% against a typical −0.5%.160th of 200
- Size₹ 127.4 Cr. market value against a typical ₹ 507.7 Cr. (1st = largest).139th of 199
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 24 | 26 | 31 | 26 | 27 | 26 | 28 | 24 | 25 | 27 | 31 | 25 |
| Expenses | 19 | 21 | 27 | 22 | 22 | 22 | 24 | 20 | 22 | 23 | 29 | 21 |
| Operating Profit | 4 | 5 | 5 | 4 | 5 | 5 | 5 | 4 | 4 | 4 | 2 | 3 |
| OPM % | 18.7% | 19.2% | 15.1% | 17% | 18.9% | 17.3% | 16.8% | 15.9% | 13.8% | 14.1% | 7.8% | 13.5% |
| Other Income | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 5 | 6 | 4 | 5 | 5 | 5 | 4 | 4 | 3 | 4 | 3 | 3 |
| Tax % | 25.2% | 25.1% | 34.6% | 25% | 26.1% | 24.2% | 24% | 25.1% | 25% | 11.3% | 43.9% | 25.7% |
| Net Profit | 4 | 4 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 4 | 2 | 2 |
| EPS in Rs | 3.13 | 3.62 | 2.11 | 2.6 | 2.88 | 2.79 | 2.41 | 2.16 | 1.98 | 2.79 | 1.29 | 1.75 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 10%
- 5 Years
- 17%
- 3 Years
- 1%
- TTM
- 2%
- 10 Years
- 14%
- 5 Years
- 17%
- 3 Years
- −8%
- TTM
- −24%
- 10 Years
- 12%
- 5 Years
- 19%
- 3 Years
- −14%
- TTM
- —
- 10 Years
- 13%
- 5 Years
- 12%
- 3 Years
- 10%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Panchsheel Organics | ₹ 103.60 | ₹ 127 Cr. | 13.3x | 1x | 8% | — |
| Swiggy | ₹ 176.70 | ₹ 48,775 Cr. | — | 3.6x | −29.1% | −18% |
| Delhivery | ₹ 370.00 | ₹ 27,724 Cr. | 212.4x | 3.6x | 1.6% | 1.5% |
| Urban Company | ₹ 132.65 | ₹ 20,457 Cr. | — | 8.9x | −11.9% | −15.1% |
| Sagility | ₹ 44.10 | ₹ 20,645 Cr. | 19.9x | 2x | — | 13% |
| Indegene | ₹ 570.00 | ₹ 13,763 Cr. | 28.4x | 3.8x | 13.9% | 11.4% |
Management
- Mahendra A. Turakhia
- Executive Chairman of the Board, Managing Director
- Deepak Shah
- Chief Financial Officer
- Sonia Verma
- Compliance Officer, Company Secretary
- Kishore A. Turakhia
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.